Keywords: DICOM; Digital Imaging and Communications in Medicine; GEMM; genetically engineered mouse model; KP; KRAS TP53; micro-CT; micro-computed tomography; MTC; mass of the thoracic cavity; PLK1; polo-like kinase 1; RECIST; Response Evaluation Criteria in Soli
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Meiosis; Phosphorylation; Sumoylation; Ginkgolic acid; AURKs; PLK1; GA; ginkgolic acid; OA; okadaic acid; SUMO; Small Ubiquitin-like Modifiers;
Keywords: Plk1; Selectivity; Polo-box domain; Cryptic binding pocket;
Keywords: Ab; Antibody; ABC; ATP-binding cassette; AIOM; Associazione Italiana di Oncologia Medica; ALCAM; Activated leukocyte cell adhesion molecule; APOD; Apolipoprotein D; AR; androgen receptor; AURKA; Aurora kinase A; AURKB; Aurora kinase B; BCS; Biopharmaceuti
Keywords: Indolizine; Dimethoxytriazine; Antitumor agent; PLK1; Polo-like kinase 1 inhibitor; O-demethylation; Hilbert–Johnson transposition
Keywords: DMA; 2-(dimethylamino)ethyl methacrylate; QDMA; quaternized 2-(dimethylamino)ethyl methacrylate; DEA; 2-(diethylamino)ethyl methacrylate; DPA; 2-(diisopropylamino)ethyl methacrylate; MEMA; N-(morpholino)ethyl methacrylate; FOMA; fluorooctyl methacrylate;
Keywords: ALAS1; δ-aminolevulinate synthase 1; ANGPTL3; angiopoietin-like 3; FVII; factor VII; FXI; factor XI; GCGR; glucagon receptor; HCC; hepatocellular carcinoma; HCV; hepatitis C virus; HoFH; homozygous familial hypercholesterolemia; KSP; kinesin spindle prot
Keywords: Plk1; Polo-like kinase; Polo-box domain; Phosphoamino acid mimetic;
Polo-like kinase 1 inhibitor BI 6727 induces DNA damage and exerts strong antitumor activity in small cell lung cancer
Keywords: PLK1; BI 6727; Small cell lung cancer; DNA damage;
The vanillin derivative 6-bromine-5-hydroxy-4-methoxybenzaldehyde induces aberrant mitotic progression and enhances radio-sensitivity accompanying suppression the expression of PLK1 in esophageal squamous cell carcinoma
Keywords: BVAN08; Mitotic catastrophe; PLK1; Microtubule assembly; Radio-sensitivity;
Cyclin-dependent kinase 1-mediated phosphorylation of YES links mitotic arrest and apoptosis during antitubulin chemotherapy
Keywords: YES; Mitotic phosphorylation; CDK1; Taxol sensitivity; Chemotherapy; CDK1; cyclin-dependent kinase 1; CDKN1A (p21); cyclin-dependent kinase inhibitor 1A; CRISPR; clustered regularly-interspaced short palindromic repeats; KO; knockout; Plk1; Polo-like kina
The diverse functions of the hepatitis B core/capsid protein (HBc) in the viral life cycle: Implications for the development of HBc-targeting antivirals
Keywords: Hepatitis B virus; HBV; HBV core antigen; HBc; HBc structure; HBc phosphorylations; PLK1; Core allosteric modulators; CAMs;
Silencing circular RNA hsa_circ_0000977 suppresses pancreatic ductal adenocarcinoma progression by stimulating miR-874-3p and inhibiting PLK1 expression
Keywords: hsa_circ_0000977; miR-874-3p; ceRNAs; PLK1; PDAC proliferation; CircRNAs; Circular RNAs; RBP; RNA-binding protein; miRNA; microRNA; PLK1; Polo like kinase 1; PDAC; pancreatic ductal adenocarcinoma; ceRNAs; Competing endogenous RNAs; siRNA; small interferi
DDX3 in HIV-1 infection and sensing: A paradox
Keywords: Dendritic cells; HIV-1; Type I interferon response; RNA sensing; DDX3; MAVS; DC-SIGN; PLK1;
Design, synthesis, and biological evaluation of polo-like kinase 1/eukaryotic elongation factor 2 kinase (PLK1/EEF2K) dual inhibitors for regulating breast cancer cells apoptosis and autophagy
Keywords: Apoptosis; Autophagy; Breast cancer; EEF2K; Kinase inhibitor; PLK1;
Potential role for microRNA in regulating hypoxia-induced metabolic suppression in jumbo squids
Keywords: OMZ; oxygen minimum zone; PO2; partial pressure of oxygen; Pcrit; passive pharyngeal critical closing pressure; miRNA; microRNA; miRISC; miRNA-induced RNA silencing complex; ROS; reactive oxygen species; NOX4; NADPH oxidase 4; ERK/MAPK; extracellular sign
Structure-based optimization of a series of selective BET inhibitors containing aniline or indoline groups
Keywords: BRD4; BI2536; Indoline; WPF binders; c-Myc; PD-L1; BCPs; Bromodomain-containing proteins; BET; bromodomain and extra-terminal; BRD4-BD1; first bromodomain of BRD4; CREB; cyclic-AMP response element binding protein; FA; fluorescence anisotropy; FBDD; fragm
Original ArticleSmall molecule inhibition of polo-like kinase 1 by volasertib (BI 6727) causes significant melanoma growth delay and regression in vivo
Keywords: Melanoma; Plk1; BI 6727; Volasertib;
PARP, transcription and chromatin modeling
Keywords: ABCA1; ATP-binding cassette transporter A1; ADP-ribosylation; adenosine diphosphate ribosylation; ALC1; amplified in-liver-cancer 1; AR; androgen receptor; ARH3; ADP-ribosylhydrolase 3; ART; ADP-ribosyl transferase; ASF/SF2; alternative splicing factor/sp
Expanding perspectives on the significance of mitophagy in cancer
Keywords: ALS; amyotrophic lateral sclerosis; AR; androgen receptor; ASC; apoptosis-associated speck-like protein containing a CARD; ATM; ataxia telangiectasia mutated; BCL-2; breakpoint cluster locus-2; BCL-XL; BCL2-like 1 long; BNIP3; BCL2 interacting protein 3;
Recruitment of PP1 to the centrosomal scaffold protein CEP192
Keywords: CEP192; Protein phosphatase one; Polo-like kinase one; Mitosis; Centrosome; PLK1; Polo-like kinase 1; Nek2A; NIMA-related kinase 2A; CEP192; centrosomal protein of 192Â kDa; PCM; pericentriolar matrix; PP1; protein phosphatase 1;
Modulating angiogenesis with integrin-targeted nanomedicines
Keywords: (RGD)m; RGD mimetics; 4-NQO; 4-nitroquinoline 1-oxide; AAA; Abdominal Aortic Aneurysms; ADA; 8-Amino-3,6-Dioxaoctonoic Acid; AH-GDM; Aminohexyl-Geldanamycin; ami; Amide; AP-2α; Activating Protein 2α; ARMS; Alveolar Rhabdomyosarcoma; ATO; Arsenic Trioxid
Discovery of a series of dihydroquinoxalin-2(1H)-ones as selective BET inhibitors from a dual PLK1-BRD4 inhibitor
Keywords: BRD4 inhibitor; Kinase; BI-2536; Dihydroquinoxalin-2(1H)-one; PLK1; Polo-like Kinase 1; JAK2; Janus kinase 2; PTMs; post-translational modifications; KAc; acetylated lysine; BET; Bromodomain and Extra-Terminal; P-TEFb; positive transcription elongation fa
Structure-based design and synthesis of imidazo[1,2-a]pyridine derivatives as novel and potent Nek2 inhibitors with in vitro and in vivo antitumor activities
Keywords: Nek2 inhibitors; Imidazo[1,2-a]pyridine; Antitumor activity; Selectivity; Nek2; NIMA-related kinase 2; Nlp; ninein-like protein; SAC; spindle assembly checkpoint; Mad1/2; mitotic arrest deficient 1/2; Hec1; highly expressed in cancer 1; CIN; chromosome in
Original articleDecreased PLK1 expression denotes therapy resistance and unfavourable disease-free survival in rectal cancer patients receiving neoadjuvant chemoradiotherapy
Keywords: CRT; chemoradiotherapy; DSB; double-strand break; FFPE; formalin-fixed paraffin-embedded; MRI; magnetic resonance imaging; MTA; microtubule-targeting agent; Plk1; Polo-like kinase 1; TMA; tissue microarray; Chemoradiotherapy; Polo-like kinase 1; Predictiv
MiR-509-3-5p causes aberrant mitosis and anti-proliferative effect by suppression of PLK1 in human lung cancer A549 cells
Keywords: miR-509-3-5p; PLK1; Aberrant mitosis; Cisplatin; Adriamycin; DNA damage response;
Nanoparticle-mediated siRNA delivery assessed in a 3D co-culture model simulating prostate cancer bone metastasis
Keywords: DHT; dehydrothermal; MMP9; matrix metalloproteinase 9; MTT; 3-(4,5dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; NF-κB; nuclear factor-κB; nHA; nanohydroxyapatite; PLK1; polio-like kinase 1; siRNA; small interfering RNA; Prostate cancer cells; O
In silico identification of putative bifunctional Plk1 inhibitors by integrative virtual screening and structural dynamics approach
Keywords: Plk1; Bifunctional inhibitors; Structure based virtual screening; Molecular dynamics simulation; Pharmacophore
MST2 phosphorylation at serine 385 in mitosis inhibits its tumor suppressing activity
Keywords: CDK1; cyclin-dependent kinase 1; LATS1/2; large tumor suppressor 1/2; MST1/2; mammalian sterile 20-like kinase 1/2; PLK1; polo-like kinase 1; TAZ; transcriptional co-activator with PDZ binding domain; YAP; yes-associated protein; MST2; Mitotic phosphoryla
JIP4 is a PLK1 binding protein that regulates p38MAPK activity in G2 phase
Keywords: JIP4; PLK1; p38MAPK; G2 phase; Mitosis;
Therapeutic polo-like kinase 1 inhibition results in mitotic arrest and subsequent cell death of blasts in the bone marrow of AML patients and has similar effects in non-neoplastic cell lines
Keywords: PLK1; Polo-like kinase 1; AML; acute myeloid leukemia; BMB; bone marrow biopsies; AML-MRC; AML with myelodysplasia related changes; CAE; chloroacetate esterase; HPF; high power field; HSCT; hematopoietic stem cell transplantation; AML; PLK1 inhibition; BI
The Catalytic Subunit of DNA-Dependent Protein Kinase Coordinates with Polo-Like Kinase 1 to Facilitate Mitotic Entry
Keywords: DNA-PKcs; DNA-dependent protein kinase catalytic subunit; Plk1; polo-like kinase 1; PBD; polo box domain;
Holliday junction resolution: Regulation in space and time
Keywords: DNA repair; Cell-cycle; Recombination; Nuclease; Resolvase; Mus81; Mms4; EME1; Yen1; GEN1; Cdc5; PLK1; Slx1; Slx4;
Depletion of IK causes mitotic arrest through aberrant regulation of mitotic kinases and phosphatases
Keywords: PARP; poly ADP ribose polymerase; PLK1; polo-like kinase 1; PP1; protein phosphatase 1; PP2A; protein phosphatase 2A; PP6; protein phosphatase 6; Aurora A; CDK1; IK; Mitotic arrest; Protein phosphatase;
Crystal structure of triple-BRCT-domain of ECT2 and insights into the binding characteristics to CYK-4
Keywords: ECT2; the epithelial cell transforming protein 2; DH-PH; Dbl homology domain and Pleckstrin homology domain; Plk1; Polo-like kinase 1; MKLP1; mitotic kinesin-like protein 1; ITC; isothermal titration calorimetry; TEV; tobacco etch virus; IPTG; isopropyl
APC/CCdh1-dependent degradation of Cdc20 requires a phosphorylation on CRY-box by Polo-like kinase-1 during somatic cell cycle
Keywords: Cdc20; Degron; CRY box; APC/CCdh1; Plk1; Phosphorylation;
p53 Suppresses E2F1-dependent PLK1 expression upon DNA damage by forming p53-E2F1-DNA complex
Keywords: PLK1; p53; E2F1; Transcription regulation; DNA damage;
Purification and biochemical analysis of catalytically active human cdc25C dual specificity phosphatase
Keywords: cdc25C; Dual-specificity phosphatases; cdk activation; Purification; 3-OMFP; 3-O-methylfluorescein phosphate; BME; β-mercapto-ethanol; C377S; human cdc25C mutated cysteine 377 serine; cdk; cyclin dependent kinase; DTT; dithiothreitol; IPTG; isopropyl β-
Induction of mitotic cell death by overriding G2/M checkpoint in endometrial cancer cells with non-functional p53
Keywords: EGFR; Cell cycle checkpoint; CDC25C; p38; PLK1; Mitotic catastrophe
Inhibition of polo-like kinase 1 in glioblastoma multiforme induces mitotic catastrophe and enhances radiosensitisation
Keywords: Glioblastoma multiforme; PLK1; GSK461364A; siRNA; Radiation;
Survivin regulates Plk1 localization to kinetochore in mouse oocyte meiosis
Keywords: Survivin; Plk1; Kinetochore; Oocyte; Meiosis
Menthol induces cell-cycle arrest in PC-3 cells by down-regulating G2/M genes, including polo-like kinase 1
Keywords: PLK1, polo-like kinase 1; GSEA, gene set enrichment analysis; γTuRC, γ-tubulin ring complex; CRPC, castration-resistant prostate cancerDNA microarray; Prostate cancer; Menthol; Gene set enrichment analysis; PLK1
5-(2-Amino-pyrimidin-4-yl)-1H-pyrrole and 2-(2-amino-pyrimidin-4-yl)-1,5,6,7-tetrahydro-pyrrolo[3,2-c]pyridin-4-one derivatives as new classes of selective and orally available Polo-like kinase 1 inhibitors
Keywords: PLK1; Polo-like kinase; PLK2 and PLK3; Cell cycle; Cellular activity; Crystal structure;
Inhibition of Plk1 and Pin1 by 5′-nitro-indirubinoxime suppresses human lung cancer cells
Keywords: Lung cancer; 5′-Nitro-indirubinoxime (5′-NIO); Plk1; Pin1; Cdk4; Rb
MiR-100 resensitizes docetaxel-resistant human lung adenocarcinoma cells (SPC-A1) to docetaxel by targeting Plk1
Keywords: MiR-100; Plk1; Lung adenocarcinoma; Docetaxel; Chemoresistance
Investigation on PLK2 and PLK3 substrate recognition
Keywords: PLK2; PLK3; CK2; PLK1; Kinase
Phosphorylation of Tara by Plk1 is essential for faithful chromosome segregation in mitosis
Keywords: Plk1; Tara; Phosphorylation; Chromosome segregation; Mitosis;
Switching Polo-like kinase-1 on and off in time and space
Keywords: Plk1; checkpoint recovery; mitosis; DNA damage; spindle positioning; centrosome separation
A pH-sensitive cationic lipid facilitates the delivery of liposomal siRNA and gene silencing activity in vitro and in vivo
Keywords: cDNA; Complementary DNA; CHE; Cholesteryl hexadecyl ether; Chol; Cholesterol; DMEM; Dulbecco's modified Eagle medium; DMG; Dimyristoyl-sn-glycerol; DSG; Distearoyl-sn-glycerol; DODAP; 1,2-Dioleoyl-3-dimethylammonium propane; DOPC; 1,2-Dioleoyl-sn-glycero-
Overexpression of polo-like kinase 1 and its clinical significance in human non-small cell lung cancer
Keywords: PLK1; Polo-like kinase 1; NSCLC; non-small cell lung cancer; RNAi; RNA interference; RT-PCR; reverse transcript-polymerase chain reaction; Polo-like kinase 1; Non-small cell lung cancer; Immunohistochemistry; Prognosis; RNA interference; Apoptosis; Chemot